Clinical Trials Directory

Trials / Completed

CompletedNCT00469261

Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling

Tetracycline (Doxycycline) In Patients With Large Acute Myocardial Infarction TO Prevent Left Ventricular Remodeling. TIPTOP Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
110 (actual)
Sponsor
Careggi Hospital · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The aim of the study is to assess the efficacy of an antibiotic treatment with tetracycline (doxycycline) in the early stage of large reperfused acute myocardial infarction (AMI), in preventing left ventricular (LV) remodeling.

Detailed description

A myocardial interstitial matrix, that provides structural support and integrity to the myocardium, is a key element to determine post infarction left ventricular remodeling (LVR). The metalloproteinases (MMPs), an enzymatic system secreted in the extracellular medium by macrophages, has been shown to be able to degrade the most important extracellular matrix components. Various animal experimental models have demonstrated that MMP specific inhibition in the first phase of myocardial infarction is able to contrast LVR. Doxycycline, a member of the tetracyclines, has been shown to block various inflammation mediators and to attenuate MMP-2 and MMP-9 expression and activity at a sub-antimicrobial dosage. Some experimental studies on rat models have suggested an anti-remodeling effect of doxycycline in myocardial infarction. In the present study we want to evaluate if a treatment with doxycycline (100 mg b.i.d.) in the first seven days after a reperfused large (ejection fraction less than 40%) acute myocardial infarction, is effective in preventing six-month LVR.

Conditions

Interventions

TypeNameDescription
DRUGDoxycyclineDoxycycline 100 mg bid for seven days after enrollment
DRUGCurrent medical therapy for AMICurrent medical therapy for AMI

Timeline

Start date
2007-05-01
Primary completion
2011-08-01
Completion
2011-08-01
First posted
2007-05-04
Last updated
2012-09-25

Source: ClinicalTrials.gov record NCT00469261. Inclusion in this directory is not an endorsement.